Sangamo Therapeutics
SGMO
#9117
Rank
ยฃ89.94 M
Marketcap
ยฃ0.24
Share price
-6.74%
Change (1 day)
-63.56%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: ยฃ89.94 Million

As of March 2026 Sangamo Therapeutics has a market cap of ยฃ89.94 Million. This makes Sangamo Therapeutics the world's 9117th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ89.94 M-15.3%
2025ยฃ0.10 B-75.05%
2024ยฃ0.42 B462.79%
2023ยฃ75.62 M-82.22%
2022ยฃ0.42 B-47.45%
2021ยฃ0.80 B-50.01%
2020ยฃ1.61 B118.75%
2019ยฃ0.74 B-19.9%
2018ยฃ0.92 B-9.89%
2017ยฃ1.02 B487.52%
2016ยฃ0.17 B-59.73%
2015ยฃ0.43 B-35.76%
2014ยฃ0.67 B28.73%
2013ยฃ0.52 B165.66%
2012ยฃ0.19 B105.78%
2011ยฃ95.87 M-50.88%
2010ยฃ0.19 B18.58%
2009ยฃ0.16 B69.17%
2008ยฃ97.3 M-63.18%
2007ยฃ0.26 B123.77%
2006ยฃ0.11 B65.28%
2005ยฃ71.44 M-9.54%
2004ยฃ78.98 M3.5%
2003ยฃ76.3 M64.3%
2002ยฃ46.44 M-70.55%
2001ยฃ0.15 B-45.5%
2000ยฃ0.28 B

End of Day market cap according to different sources

On Mar 27th, 2026 the market cap of Sangamo Therapeutics was reported to be:

ยฃ81.42 Million
by Nasdaq info icon info icon
ยฃ89.94 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ436.95 B 485,724.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ141.77 B 157,529.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ20.34 B 22,520.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
ยฃ22.15 B 24,528.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ125.65 B 139,605.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ223.03 B 247,877.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ31.73 B 35,188.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ7.85 B 8,629.83%๐Ÿ‡บ๐Ÿ‡ธ USA